Objective: Chronic Kidney Disease (CKD) is a public health problem worldwide with increased prevalence. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), which are commonly seen in CKD, have been considered to be the important cause of morbidity and mortality. We aimed to evaluate bone mineral markers and treatments that are performed in different age groups of elderly hemodialysis (HD) patients in routine follow up.

Materials and Methods: 47 elderly HD patients undergoing maintenance HD were divided into two age groups: Group I early elderly (65-74 years old) and Group II mid elderly (75-84 years old). Features of the groups and differences in laboratory parameters and treatment administrations between groups were analyzed.

Results: The mean age was 72.9±4.5 years. A total of 51.1% of patients were women and 40.4 % had diabetes mellitus (DM). Serum intact parathyroid hormone (iPTH) levels were lower while vitamin D replacement and phosphorus binding medication were less in group II (P<0.05). PTH levels (r= - 0.307, P= 0.017), serum P (r= - 0.291, P= 0.024) and albumin levels (r= - 0.291, P=0.024) were found inversely correlated with age.

Conclusion: iPTH levels were found lower and medication usage was less in mid elderly HD patients. DM had no effect on iPTH levels.